Biotech and medical business blog
Visit BioHealth Investor
Analyst Research Calls Impacting Biotechs (ALXN, OSCI, SGMO, VVUS, CRA)
Posted on May 29, 2008
There were some research calls that are affecting many shares of biotech stocks this morning, as follows:Alexion Pharmaceuticals (NASDAQ: ALXN) started as Buy at Piper Jaffray, shares up almost 2%.Oscient Pharmaceuticals (NASDAQ: OSCI) started as Neutral at Piper Jaffray; shares flat as a thin volume stock.Sangamo Biosciences (NASDAQ: SGMO) Started as Sell at Brean Murray; [...]...
Original article linkTags:
biotech default explanation





Subscribe to BioHealth Investor